Vu Quan Anh 4
4 · Monopar Therapeutics · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Vu Quan Anh
Chief Financial Officer
Transactions
- Award
Stock Options
2025-12-02+7,135→ 7,135 totalExercise: $75.94Exp: 2035-12-02→ Common Stock (7,135 underlying) - Award
Restricted Stock Units
2025-12-02+9,826→ 9,826 totalExercise: $0.00→ Common Stock (9,826 underlying)
Footnotes (2)
- [F1]Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter.
- [F2]RSUs vest 6/48ths on June 30, 2026, and 3/48ths per quarter thereafter.